SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Y-mAbs Therapeutics Q1 EPS $(0.660) Misses $(0.620) Estimate

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.660) per share which missed the analyst consensus estimate of $(0.620) by 6.45 percent. This is a 40.43 percent decrease over losses of $(0.470) per

Benzinga · 05/07/2020 20:18

Y-mAbs Therapeutics (NASDAQ:YMAB) reported quarterly losses of $(0.660) per share which missed the analyst consensus estimate of $(0.620) by 6.45 percent. This is a 40.43 percent decrease over losses of $(0.470) per share from the same period last year.